Best Practice & Research Clinical Haematology
Volume 19, Issue 4 , Pages 701-713, December 2006

Novel antibody-based therapy for acute lymphoblastic leukaemia

  • Nicola Gökbuget, MD

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +49 69 6301 6365; Fax: +49 69 6301 7463.
  • Dieter Hoelzer, MD, PhD (Professor of Internal Medicine and Head of the Department)

Head of Study Center

J W Goethe University Hospital, Medical Clinic III, Theodor Stern Kai 7, 60590 Frankfurt, Germany

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(06)00044-2

doi:10.1016/j.beha.2006.06.008

Best Practice & Research Clinical Haematology
Volume 19, Issue 4 , Pages 701-713, December 2006